Esmolol® is indicated for supraventricular tachycardia and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.
Amomed Pharma GmbH is the MA-Holder and AOP Orphan has the distribution rights.
Please use the emc links below to download PIL:
Esmolol 2,500mg Powder:
Esmolol 10mg/ml solution: